JAK inhibitor Tofacitinib alleviated acute hepatitis induced by lipopolysaccharide/D-galactosamine in mice

Xinyue Zhang(Chongqing Medical University), Yongqiang Yang(Chongqing Medical University), Longjiang Li(Sichuan University), Ruyue Shao(Chongqing Medical and Pharmaceutical College), Tang Li(Beijing Proteome Research Center), Li Zhang(Harbin Medical University), Ling Lin(Haikou City People's Hospital), Yuhua Ma(Shanghai East Hospital), Kai Hu(Jiangsu University), Min Zhu(Soochow University)
Research Square
August 10, 2022
10.21203/rs.3.rs-1901272/v1
Cited by 0

Related Papers

Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study
|The Lancet Public Health|2020|1.8k
Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage
|Alzheimer s & Dementia|2020|256
Liver Sinusoidal Endothelial Cell Lectin, LSECtin, Negatively Regulates Hepatic T-Cell Immune Response
|Gastroenterology|2009|117
<i>PSEN1, PSEN2</i>, and <i>APP</i> mutations in 404 Chinese pedigrees with familial Alzheimer's disease
|Alzheimer s & Dementia|2020|89
Induction of ER stress-mediated apoptosis by ceramide via disruption of ER Ca2+ homeostasis in human adenoid cystic carcinoma cells
|Cell & Bioscience|2014|88